Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-21-001032
Filing Date
2021-02-17
Accepted
2021-02-17 15:10:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP clrb_21621.htm SC 13G 56364
  Complete submission text file 0001085146-21-001032.txt   58064
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 21644223
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

EIN.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G